Lei Qian Selected Research

mazdutide

1/2022	A phase 1b randomised controlled trial of a glucagon-like peptide-1 and glucagon receptor dual agonist IBI362 (LY3305677) in Chinese patients with type 2 diabetes.
9/2021	IBI362 (LY3305677), a weekly-dose GLP-1 and glucagon receptor dual agonist, in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple ascending dose phase 1b study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lei Qian Research Topics

Disease

14	Infections 06/2022 - 01/2012
13	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2008
9	Neoplasms (Cancer) 01/2022 - 01/2014
8	COVID-19 02/2022 - 10/2021
7	Fibrosis (Cirrhosis) 01/2022 - 10/2020
6	Insulin Resistance 03/2019 - 10/2008
5	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 11/2011
5	Lung Neoplasms (Lung Cancer) 01/2022 - 09/2016
5	Obesity 01/2022 - 11/2008
5	Inflammation (Inflammations) 01/2021 - 08/2011
5	Diabetes Mellitus 03/2019 - 10/2008
4	Whooping Cough (Pertussis) 01/2022 - 01/2016
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021 - 11/2020
3	Herpes Zoster 03/2022 - 01/2019
3	Anaphylaxis (Anaphylactic Shock) 01/2022 - 06/2018
3	Febrile Seizures (Febrile Seizure) 01/2022 - 05/2014
3	Hypertrophy 01/2022 - 10/2020
3	Heart Failure 01/2021 - 11/2020
3	Human Influenza (Influenza) 01/2021 - 01/2016
3	Asthma (Bronchial Asthma) 05/2020 - 01/2016
3	Pre-Eclampsia (Preeclampsia) 05/2020 - 01/2015
3	Diphtheria 01/2019 - 02/2013
3	Tetanus 01/2019 - 02/2013
2	Fever (Fevers) 01/2022 - 01/2016
2	Myocardial Infarction 01/2022 - 01/2022
2	Measles 01/2022 - 01/2021
2	Adenocarcinoma of Lung 01/2022 - 01/2017
2	Cytokine Release Syndrome 12/2021 - 09/2021
2	Pain (Aches) 01/2021 - 01/2019
2	Dementia (Dementias) 01/2021 - 01/2021
2	Cardiomyopathies (Cardiomyopathy) 01/2021 - 10/2020
2	Cognitive Dysfunction 10/2019 - 07/2019
2	Hepatitis B 01/2019 - 12/2014
2	Hyperlipidemias (Hyperlipidemia) 10/2017 - 01/2010
2	Hepatocellular Carcinoma (Hepatoma) 01/2016 - 01/2016
2	Parkinson Disease (Parkinson's Disease) 07/2010 - 05/2010
2	Hyperglycemia 01/2010 - 02/2009
2	Glucose Intolerance 02/2009 - 10/2008
1	Gonorrhea 06/2022
1	Appendicitis 01/2022
1	Shoulder Injuries 01/2022
1	Autism Spectrum Disorder 01/2022

Drug/Important Bio-Agent (IBA)

27	VaccinesIBA 06/2022 - 01/2012
7	Pharmaceutical PreparationsIBA 12/2021 - 06/2005
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2011
6	CytokinesIBA 12/2021 - 01/2015
5	Insulin (Novolin)FDA Link 06/2017 - 10/2008
4	2019-nCoV Vaccine mRNA-1273IBA 02/2022 - 12/2021
4	MicroRNAs (MicroRNA)IBA 01/2022 - 09/2016
4	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 01/2022 - 01/2019
4	Isoproterenol (Isoprenaline)FDA LinkGeneric 07/2021 - 10/2020
4	Interleukin-6 (Interleukin 6)IBA 01/2021 - 11/2015
4	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2021 - 01/2016
4	Insulin Lispro (Humalog)FDA Link 06/2018 - 01/2017
3	Herpes Zoster VaccineIBA 03/2022 - 01/2019
3	gamma- hydroxy- gamma- ethyl- gamma- phenylbutyramide (HEPB)IBA 01/2022 - 12/2014
3	Cholinergic Agents (Cholinergics)IBA 01/2022 - 07/2019
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 11/2008
3	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2020 - 01/2016
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 01/2010
3	EnzymesIBA 05/2017 - 11/2008
3	Nonesterified Fatty Acids (NEFA)IBA 07/2013 - 11/2008
2	Polysaccharides (Glycans)IBA 06/2022 - 03/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 06/2022 - 12/2021
2	mazdutideIBA 01/2022 - 09/2021
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 09/2021
2	Glucagon Receptors (Glucagon Receptor)IBA 01/2022 - 09/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2017
2	CollagenIBA 07/2021 - 01/2021
2	Adrenergic Agents (Adrenergic Drugs)IBA 07/2021 - 11/2020
2	periplocymarinIBA 07/2021 - 01/2021
2	Immune Checkpoint InhibitorsIBA 04/2021 - 11/2020
2	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 01/2021 - 07/2019
2	LigandsIBA 01/2021 - 11/2020
2	LipopolysaccharidesIBA 05/2020 - 11/2015
2	Interleukin-33IBA 01/2020 - 05/2017
2	Interleukin-10 (Interleukin 10)IBA 01/2020 - 11/2015
2	Peptides (Polypeptides)IBA 10/2019 - 01/2015
2	Amyloid (Amyloid Fibrils)IBA 10/2019 - 07/2019
2	Hypoglycemic Agents (Hypoglycemics)IBA 03/2019 - 01/2017
2	InsulinsIBA 06/2018 - 01/2017
2	CholesterolIBA 10/2017 - 01/2010
2	InterleukinsIBA 05/2017 - 01/2015
2	Protamines (Protamine Sulfate)FDA Link 01/2017 - 01/2017
2	Angiopoietin-2IBA 03/2016 - 05/2015
2	Fatty Acids (Saturated Fatty Acids)IBA 05/2010 - 01/2007
2	Glucose (Dextrose)FDA LinkGeneric 02/2009 - 10/2008
1	MenACWYIBA 06/2022
1	Conjugate VaccinesIBA 06/2022
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2022
1	aluminum sulfate (alum)IBA 01/2022
1	pembrolizumabIBA 01/2022
1	dulaglutideIBA 01/2022

Therapy/Procedure

10	Therapeutics 01/2022 - 06/2005
5	Glycemic Control 01/2020 - 05/2015
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2019 - 11/2008
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2021
2	Immunotherapy 04/2021 - 01/2016
1	Lasers (Laser) 01/2022
1	Cystectomy 01/2022